Article
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression
16 Sept 2019
Abstract excerpt
ABSTRACT Tissue fibrosis is a chronic disease driven by persistent fibroblast activation that has recently been linked to epigenetic modifications. Here, we screened a small library of epigenetic small-molecule modulators to identify compounds capable of inhibiting or reversing TGFβ-mediated fibroblast activation. We identified pracinostat, an HDAC inhibitor, as a potent attenuator of lung fibroblast activation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
